| 注册
首页|期刊导航|中国医学创新|铁死亡诱导剂在结直肠癌中的研究进展

铁死亡诱导剂在结直肠癌中的研究进展

陈伟鸿 苏小苹 苏宇超 黄栋钦 许永鹏

中国医学创新2023,Vol.20Issue(34):180-184,5.
中国医学创新2023,Vol.20Issue(34):180-184,5.DOI:10.3969/j.issn.1674-4985.2023.34.040

铁死亡诱导剂在结直肠癌中的研究进展

Research Progress of Ferroptosis Inducers in Colorectal Cancer

陈伟鸿 1苏小苹 1苏宇超 1黄栋钦 1许永鹏1

作者信息

  • 1. 福建省安溪县医院 福建 安溪 362400
  • 折叠

摘要

Abstract

Colorectal cancer(CRC)is the third most common cancer in the world,and traditional treatment programs have poor efficacy in patients with advanced CRC.Therefore,novel therapeutic strategies may be helpful to improve the treatment and prognosis of CRC patients.Ferroptosis is an iron-dependent regulatory cell death characterized by the increase of iron and reactive oxygen species(ROS).CRC cells have high levels of iron and ROS,and inducing ferroptosis may become a new treatment method for CRC.This paper reviews the current research progress on the mechanism of ferroptosis and introduces the latest inducers of ferroptosis,including small molecule compounds and nanoparticles,and provides ideas for developing new treatment plans for CRC.

关键词

结直肠癌/铁死亡/小分子化合物/纳米颗粒

Key words

Colorectal cancer/Ferroptosis/Small molecule compound/Nanoparticle

引用本文复制引用

陈伟鸿,苏小苹,苏宇超,黄栋钦,许永鹏..铁死亡诱导剂在结直肠癌中的研究进展[J].中国医学创新,2023,20(34):180-184,5.

基金项目

安溪县科技计划项目(2022S002) (2022S002)

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文